Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Accumulated Depreciation & Amortization (2016 - 2025)

Fortress Biotech has reported Accumulated Depreciation & Amortization over the past 13 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $5.1 million for Q4 2025, down 57.52% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (down 57.52% YoY), and the annual figure for FY2025 was $5.1 million, down 57.52%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.1 million at Fortress Biotech, up from $5.1 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for FBIO hit a ceiling of $13.3 million in Q1 2023 and a floor of $4.9 million in Q1 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $9.1 million (2023), compared with a mean of $9.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 47.0% in 2021 and later plummeted 58.05% in 2025.
  • Fortress Biotech's Accumulated Depreciation & Amortization stood at $9.4 million in 2021, then skyrocketed by 32.49% to $12.4 million in 2022, then fell by 28.56% to $8.9 million in 2023, then soared by 36.17% to $12.1 million in 2024, then plummeted by 57.52% to $5.1 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $5.1 million (Q4 2025), $5.1 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.